| Just Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > PR > It's CNN! They Want To Talk To You! |
|
Just Other Articles - It's CNN! They Want To Talk To You!
Being invited to appear on radio and television used to be reserved for top company executives and spokespersons. Until quite recently, the chance of being invited to make a media appearance was extremely small, even for the hi According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ghest echelon. Today, almost anyone in responsible positions could be called on to interview. Sweeping changes in broadcast and print media have created a multitude of channels and journals of specific interest; some of them gl ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in bal in nature. This information-starved media creates immense opportunities and significant challenges for individuals and organizations. Disaster or opportunity? Most people are very apprehensive and unprepared for me lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. dia interviews and press conferences. Just one “off the cuff” comment or slip of the tongue and years of company image and personal career building can go right down the drain. However, to decline an appearance allows a great o here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe portunity for getting your message out to disappear without a trace. So how do you turn a potential disaster into an enormous advantage? By learning some simple rules and doing some on-camera training, you can learn the skills d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro equired to do credit to yourself, your organization and your industry. If a television appearance is imminent, arrange a visit to your local television studio to watch the news being broadcast. It may surprise you. Handli ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ng that critical call from the press The caller is usually a member of the production team, customarily a researcher. In some cases, the caller may be the journalist who wants to interview you. He or she is not a receptioni easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi t or a telephonist. You should be careful how you handle your conversation with them. Interview the caller and write down their answers. Their willingness to respond is an exceptional indicator of their integrity. Do not rus nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically h to accept or decline the interview, just ask the following questions: • What is the name of the broadcaster or publication? • What is the name of the program or working title of the article? • Who is the journalis and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ , correspondent or interviewer? • Why is this article being written or program being made? (They probably know something you don’t know.) • What is their angle? (Journalists always take an editorial approach or slant ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi to stories. This is the story’s angle.) • Who else’s views are being sought? Who else will be there? • Will it be broadcast live or recorded; in a studio or on location? • When do they want you? • Are t ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a hey showing any videos, models or graphics during the segment or program? And when can someone from you organization come to see them? (This is so that you are not taken by surprise.) • If you have your materials, can the dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod be included? (These would have to be prepared in advance and the integration of these would take some time to rehearse prior to the actual broadcast.) Tell the caller that you will get back to them in 10 minutes This give cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin s you time to decide what to do. Your decision should not be based on fear or flattery. It should be a normal management decision. You should not refuse as a matter of course since the presenter could refer to your refusal on tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen air and create the impression of guilt by refusal. You need to ask yourself the following questions? • Is appearing of benefit to me? • Is it of benefit to my company? • Am I the best person to appear? • Do w t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel want to be seen to associate with the other guest or guests? • Do we have adequate preparation time? • Does the journalist or program have a good reputation? • Do we trust the journalist? • What will happ ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust en if we do not accept the invitation? Accept or decline? It is of absolutely no use to accept the invitation if you will be faced with a couple of zealots, radicals or a protagonist who hates everything you do and ever y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products thing you stand for. It is also impossible to compete with a highly edited tape feature, which negatively expounds the issue without you having your own taped segment to refute and set the record straight. You should remember . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de that when appearing on the media, you are your organization, and even your industry, personified. Reputations and careers are at stake here! If, after careful consideration, you do accept the interview, then extensive prior pl elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip nning is required to turn this challenge into a golden opportunity. An opportunity which effectively allows you to communicate your message to an extremely large audience, sometimes numbering in the tens or hundreds of millions tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:From Job Interview to Job Owner: 7 Tips
|